Semaglutide cost effective versus dulaglutide in Japan

  • PDF / 186,352 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 20 Downloads / 208 Views

DOWNLOAD

REPORT

PharmacoEconomics & Outcomes News 862, p26 - 19 Sep 2020 Semaglutide cost effective versus dulaglutide in Japan Injectable once-weekly semaglutide appears to be cost effective compared with weekly dulaglutide in patients with type 2 diabetes mellitus (T2D) in Japan, according to findings of a Novo Nordisk-funded study published in Advances in Therapy. A cost-of-control model populated with data on prespecified endpoints in the randomised SUSTAIN† 7 trial, and based on attainment of HbA1c††

Data Loading...

Recommend Documents
Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Span

142 17 997KB

Synflorix cost effective versus PCV13 in Taiwan

208 39 182KB

Influenza vaccination in pregnant women cost effective in Japan

114 28 166KB

Heplisav-B cost effective versus Engerix-B

168 82 166KB

Gender-neutral HPV vaccination cost effective versus girls-only

173 83 169KB

Dulaglutide

124 27 166KB

Cost-Effective

168 109 57MB

Atorvastatin cost effective in T2DM

163 57 182KB

Atomoxetine cost-effective in ADHD

158 88 139KB

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus On

142 74 392KB

Highly Cost-Effective Intervention

195 83 57MB

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment o

135 78 788KB